Many patients at Seattle Cancer Care Alliance (SCCA) receive promising therapies by taking part in clinical trials. These research studies are done by physician-scientists from SCCA, Fred Hutchinson Cancer Research Center and UW Medicine. They test new treatments or new ways to use current treatments.
Every advance in cancer treatment in recent years has come out of clinical trials. We offer more active clinical trials than anywhere else, which means more treatment options for patients like you.
Melanoma treatment has advanced dramatically in the past decade, allowing more patients to live longer, free of any signs or symptoms of the disease. Still, today’s options do not work as well as we want for every person, and we are actively pursuing more effective therapies.
For some people, taking part in a clinical study may be the best treatment choice. Access to clinical studies by researchers at SCCA and our founding organizations Fred Hutch and UW Medicine is often the main reason many patients come to SCCA. We have a wide variety of clinical studies for melanoma, including studies of vaccines, immune cell treatments and other immunotherapies.
Our doctors are working toward being able to stage and characterize melanoma down to the molecular level. Defining the genetic changes that cause different types of melanoma will help us identify patients whose disease may respond better to more customized regimens.